Bluestar Silicones Launches PFAS-Free Liquid Rubber
The new Silbione LSR 4755 PF material is designed for healthcare devices needing long-term patient contact.
Updated on Oct. 22, 2026 in Healthcare
Live Poll
Should companies be required to prioritize sustainable materials in medical device manufacturing?
Bluestar Silicones has introduced Silbione LSR 4755 PF, a liquid silicone rubber specifically developed for healthcare device manufacturing. This PFAS-free material supports applications involving up to 30 days of patient contact.
Why it matters
The product launch helps healthcare device manufacturers meet evolving regulatory requirements and sustainability goals. By offering a PFAS-free alternative, the company addresses industry-wide pressure to eliminate per- and polyfluoroalkyl substances from medical supply chains.
Silbione LSR 4755 PF is rated for patient contact up to 30 days and has been evaluated according to ISO 10993 requirements. This material is designed to serve the North American healthcare device market.
The players
Bluestar Silicones
This organization is a global manufacturer of silicone materials used in various industrial and healthcare applications.
The details
The elastomer features integrated lubricating technology that creates a non-stick surface, while delayed oil bleed technology is utilized to reduce mold fouling during production. These advancements allow manufacturers to maintain device performance while adhering to strict safety standards.
Timeline
Bluestar Silicones launched the Silbione LSR 4755 PF material on October 22, 2026.
Market Landscape
The introduction of Silbione LSR 4755 PF aligns with broader shifts toward safer medical materials as defined by the ISO 10993 requirements. This product positions Bluestar Silicones to better compete in a market increasingly prioritizing the phase-out of PFAS chemicals in healthcare infrastructure.
For healthcare device manufacturers, this new material offers a streamlined way to improve device longevity and safety profiles without requiring complex re-tooling. The non-stick and anti-fouling properties may eventually lead to higher-quality medical devices for patients and reduced manufacturing costs.
The takeaway
Healthcare manufacturers can leverage these new silicone materials to reach sustainability targets while ensuring patient safety during extended contact. Adopting such materials reduces reliance on traditional compounds, potentially simplifying compliance across international markets.
Further reading
Learn more about the latest innovations in medical materials on our Healthcare page.
Source note: This article includes information reported by Rubber Journal Asia -News on Rubber machinery , Manufacturers , Rubber chemical producers and Rubber processors.
Live Poll
Should companies be required to prioritize sustainable materials in medical device manufacturing?
